4.6 Article

Lichen Sclerosus of the Male Genitalia and Urethra: Surgical Options and Results in a Multicenter International Experience with 215 Patients

Journal

EUROPEAN UROLOGY
Volume 55, Issue 4, Pages 945-956

Publisher

ELSEVIER
DOI: 10.1016/j.eururo.2008.07.046

Keywords

Lichen sclerosus; Balanitis xerotica obliterans; Urethral stricture; Urethroplasty

Ask authors/readers for more resources

Background: Surgical options in male patients with genital lichen sclerosus (LS) involving the anterior urethra still represent a challenging issue. Objective: To review the outcome of surgical treatment in patients with genital and urethral LS. Design, setting, and participants: Multicenter, international, retrospective, observational descriptive study performed in two specialized centers. Two hundred fifteen male patients underwent surgery for histologically proven genital LS involving the foreskin and/or the anterior urethra. Intervention: Circumcision (34 cases), meatotomy (15 cases), circumcision and meatotomy (8 cases), one-stage penile oral mucosal graft urethroplasty (8 cases), two-stage penile oral mucosal graft urethroplasty (15 cases), one-stage bulbar oral mucosal graft urethroplasty (88 cases), and definitive perineal urethrostomy (47 cases). Measurements: Primary outcome was considered a failure when any postoperative instrumentation was needed, including dilation, or when recurrence was diagnosed. Results and limitations: The average follow-up was 56 mo (range: 12-170 mo). Circumcision showed 100% success rate with no recurrence of the disease; meatotomy, 80% success rate; circumcision and meatotomy, 100% success rate; one-stage penile oral mucosal graft urethroplasty, 100% success rate; two-stage penile oral mucosal graft urethroplasty, 73% success rate; one-stage bulbar oral mucosal graft urethroplasty, 91% success rate; and definitive perineal urethrostomy, 72% success rate. Limitations include short follow-up for recording neoplastic degeneration and no instrument to investigate quality of life. Conclusions: Patients with LS disease restricted to the foreskin and/or external urinary meatus showed a high surgery success rate. in patients with penile urethral strictures or panurethral strictures, the use of one-stage oral graft urethroplasty showed greater success than the staged procedures. (C) 2008 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

Combination of AST to ALT and neutrophils to lymphocytes ratios as predictors of locally advanced disease in patients with bladder cancer subjected to radical cystectomy: Results from a single-institutional series

Alessandro Uleri, Rodolfo Hurle, Roberto Contieri, Pietro Diana, Nicolomaria Buffi, Massimo Lazzeri, Alberto Saita, Paolo Casale, Giorgio Guazzoni, Giovanni Lughezzani

Summary: This study aimed to investigate the role of the De Ritis ratio and neutrophils to lymphocytes ratio in predicting locally-advanced disease in bladder cancer patients. The results indicated a significant association between these two ratios and the presence of locally-advanced disease.

UROLOGIA JOURNAL (2022)

Article Oncology

Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start

Rodolfo Hurle, Giorgio Guazzoni, Piergiuseppe Colombo, Armando Santoro, Ottavio De Cobelli, Ettore Di Trapani, Gloria Nohales, Llorente Carlos, Ramon Duran-Merino, Massimo Lazzeri

Summary: This study evaluates the safety and efficacy of Oncofid-P-B in CIS patients who are unresponsive or intolerant to BCG, showing a 75% complete response rate after 12 weeks of treatment and a 40% complete response rate still after 15 months. Only 7 drug-related adverse events were reported, with drug concentrations below the limit of quantification in all plasma samples.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

Article Urology & Nephrology

Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study

Vittorio Fasulo, Nicolo Maria Buffi, Federica Regis, Marco Paciotti, Fancesco Persico, Davide Maffei, Alessandro Uleri, Alberto Saita, Paolo Casale, Rodolfo Hurle, Massimo Lazzeri, Giorgio Guazzoni, Giovanni Lughezzani

Summary: This study evaluated the accuracy of micro-ultrasound in predicting extraprostatic extension of Prostate Cancer prior to surgery. The results showed that micro-ultrasound can accurately predict extraprostatic extension at the final pathology report in patients scheduled for robot-assisted radical prostatectomy.

WORLD JOURNAL OF UROLOGY (2022)

Article Urology & Nephrology

Optimizing decision-making after ventral onlay buccal mucosa graft urethroplasty failure

Marco Bandini, Giuseppe Basile, Massimo Lazzeri, Francesco Montorsi, Benedetta Valli, Sofia Balo, Guido Barbagli

Summary: This study evaluated the factors predicting recurrence after treatment and the best rescue option for patients failing buccal mucosa graft (BMG) urethroplasty. The findings showed that stricture length >= 5 cm was the only predictor of failure. Direct visual internal urethrotomy (DVIU) was a good option as a rescue treatment, but its success rate decreased with the number of treatments performed. On the other hand, open urethroplasty improved outcomes in most patients.

BJU INTERNATIONAL (2023)

Letter Oncology

Micro-ultrasound may significantly reduce the proportion of unnecessary prostate biopsies in patients with PI-RADS 3 lesions

Pier Paolo Avolio, Massimo Lazzeri, Nicolo Maria Buffi, Giovanni Lughezzani

CANCER (2023)

Letter Urology & Nephrology

Inflammatory markers and Type 2 diabetes mellitus as prognostic risk factors in low-risk bladder cancer

Nicola Frego, Roberto Contieri, Pietro Diana, Stefano Mancon, Piergiuseppe Colombo, Massimo Lazzeri, Nicolo Maria Buffi, Paolo Casale, Rodolfo Hurle

BJU INTERNATIONAL (2023)

Meeting Abstract Oncology

URINE LYOPHILIZATION DOES NOT ALTER THE DIAGNOSTIC ACCURACY OF PROSTATE CANCER BY CANINE OLFACTION

Paola Arena, Edoardo Beatrici, Vittorio Fasulo, Pier Paolo Avolio, Nicolo Buffi, Massimo Lazzeri, Paolo Casale, Matteo Zanoni, Paolo Vota, Fabio Grizzi, Lorenzo Tidu, Paolo Sardella, Rodolfo Hurle, Cinzia Mazzieri, Giovanni Toia, Eleonora Macchi, Maria Marinozzi, Marco Guerrini, Gianluigi Taverna

ANTICANCER RESEARCH (2022)

Meeting Abstract Radiology, Nuclear Medicine & Medical Imaging

Additional value of semiquantitative parameters in clinical staging of primary prostate cancer with 68Ga-PSMA PET/CT: preliminary results of prospective single-centre cohort study

J. Jandric, M. Rodari, G. Lughezzani, N. Buffi, G. Guazzoni, P. Casale, M. Lazzeri, R. Hurle, A. Saita, K. Keus, V. Fasulo, P. Colombo, M. Cieri, M. Sollini, A. Chiti

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Meeting Abstract Urology & Nephrology

THE ROLE OF MICRO-ULTRASOUND AMONG PATIENTS WITH A PIRADS 5 LESION AT MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING

Marco Paciotti, Davide Maffei, Pier Paolo Avolio, Cesare Saitta, Vittorio Fasulo, Nicola Frego, Roberto Contieri, Alessandro Uleri, Alberto Saita, Rodolfo Hurle, Massimo Lazzeri, Paolo Casale, Giorgio Guazzoni, Nicolo Buffi, Giovanni Lughezzani

JOURNAL OF UROLOGY (2022)

Meeting Abstract Urology & Nephrology

PROSPECTIVE VALIDATION AND COMPARISON OF DIFFERENT SCORING SYSTEMS FOR THE PREDICTION OF SURGICAL OUTCOME OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY

Cesare Saitta, Pietro Diana, Alessandro Uleri, Vittorio Fasulo, Andrea Gobbo, Paola Arena, Edoardo Beatrici, Giuseppe Chiarelli, Roberto Contieri, Nicola Frego, Pier Paolo Avolio, Davide Maffei, Alberto Saita, Paolo Casale, Giorgio Guazzoni, Massimo Lazzeri, Rodolfo Hurle, Giovanni Lughezzani, Nicolo Maria Buffi

JOURNAL OF UROLOGY (2022)

Article Oncology

Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial

Roberto Contieri, Giovanni Lughezzani, Nicolo Maria Buffi, Gianluigi Taverna, Alessandro Giacobbe, Emanuele Micheli, Sabato Barra, Piergiuseppe Colombo, Elena Vanni, Giorgio Guazzoni, Massimo Lazzeri, Rodolfo Hurle

Summary: The preliminary results of this study suggest that restaging transurethral resection (ReTUR) may be safely avoided in T1 non-muscle-invasive bladder cancer (NMIBC) patients with complete resection at initial transurethral resection (TUR). Longer follow-up and larger sample size are needed to investigate the long-term oncological outcomes of this alternative approach.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy

Vittorio Fasulo, Janet E. Cowan, Martina Maggi, Samuel L. Washington, Hao G. Nguyen, Katsuto Shinohara, Massimo Lazzeri, Paolo Casale, Peter R. Carroll

Summary: By evaluating changes across serial biopsies, it is possible to identify the tumor progression in early-stage prostate cancer patients on active surveillance and determine whether they are suitable candidates for focal therapy.

EUROPEAN UROLOGY ONCOLOGY (2022)

Article Urology & Nephrology

Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy

Massimo Lazzeri, Stefano Duga, Elena Azzolini, Vittorio Fasulo, Nicolo Buffi, Alberto Saita, Giovanni Lughezzani, Elvezia M. Paraboschi, Rodolfo Hurle, Alessandro Nobili, Maurizio Cecconi, Giorgio Guazzoni, Paolo Casale, Rosanna Asselta

Summary: This study compared the hospitalization rates for COVID-19 between males exposed to 5ARIs and a control group, and found that males exposed to 5ARIs had a lower risk of hospitalization. This suggests the potential protective effect of 5ARIs against severe COVID-19.

MINERVA UROLOGY AND NEPHROLOGY (2022)

No Data Available